JK
Jitendra Kumar
About Jitendra Kumar
Data last updated:
Jitendra Kumar is a Director at Ableson Life Sciences Private Limited (since 2022). The companies operate in Home Appliances and Pharma. Ableson Life Sciences Private Limited reported revenue of ₹38 Lakh (FY 2024). Earlier, Jitendra Kumar was a Director at Acemed Healthcare Private Limited (2019–2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ableson Life Sciences Private Limited U52310WB2022PTC253103 | Director | 18 Apr 2022 | 2022 | ₹38 Lakh (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Acemed Healthcare Private Limited U74999BR2019PTC042980 | Director | 13 Aug 2019 | 2019 | ₹87.8 Lakh (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Jitendra Kumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Namita Kumari | 09575230 | Ableson Life Sciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jitendra Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jitendra Kumar
Jitendra Kumar currently holds 1 directorship: Ableson Life Sciences Private Limited (Director, since 18 Apr 2022, revenue ₹38 Lakh (FY 2024)).
Jitendra Kumar was first appointed on 13 Aug 2019 as Director at Acemed Healthcare Private Limited. The most recent appointment on record is 18 Apr 2022 at Ableson Life Sciences Private Limited.
Jitendra Kumar held 1 earlier board appointment: Acemed Healthcare Private Limited (Director, 13 Aug 2019 to 16 Mar 2022).
The current boards of Jitendra Kumar's companies include Namita Kumari (Ableson Life Sciences Private Limited).